1. Home
  2. HNVR vs SPRO Comparison

HNVR vs SPRO Comparison

Compare HNVR & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$25.04

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.22

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
SPRO
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
156.3M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
HNVR
SPRO
Price
$25.04
$1.22
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$24.50
N/A
AVG Volume (30 Days)
54.4K
1.5M
Earning Date
04-27-2026
05-13-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
111.81
EPS
0.25
N/A
Revenue
N/A
$66,802,000.00
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
$300.00
P/E Ratio
$99.16
N/A
Revenue Growth
N/A
39.24
52 Week Low
$19.91
$1.10
52 Week High
$25.61
$3.08

Technical Indicators

Market Signals
Indicator
HNVR
SPRO
Relative Strength Index (RSI) 62.24 18.94
Support Level $22.09 N/A
Resistance Level $25.61 $2.44
Average True Range (ATR) 0.68 0.16
MACD 0.08 -0.07
Stochastic Oscillator 75.82 6.19

Price Performance

Historical Comparison
HNVR
SPRO

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: